all 11 patients either demonstrated serious myelosuppression which precluded the continuation of intravenous ganciclovir therapy ( 5 patients ) or were experiencing progressive cmv retinitis despite therapy with maximum-tolerable dosages of intravenous ganciclovir ( 6 patients ) .
C0206178
cmv retinitis
C0017066
ganciclovir